Physician profile
Anish Samuel
NPI 1891012332
$6,025.74
in general payments reported to CMS, 2019-2025
33 companies · $2,700 in 2025
The $2,700 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.82 · 2020: $13.84 · 2021: $200 · 2022: $539 · 2023: $1,125 · 2024: $1,436 · 2025: $2,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,991 · Travel and Lodging: $168 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,991.03 |
| Travel and Lodging | $167.74 |
| Education | $101.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,691.31 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,647.80 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Inspire Medical Systems, INC. | $292.22 | 2024-2025 | Inspire |
| Intuitive Surgical, INC. | $263.14 | 2025 | |
| Amgen INC. | $247.97 | 2022-2025 | Tezspire, Lumakras |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.42 | 2021-2025 | Ofev, Jascayd |
| Insmed, INC. | $196.75 | 2021-2025 | Arikayce, Brinsupri |
| Pulmonx Corporation | $192.40 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Philips North America LLC | $189.79 | 2021-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $167.92 | 2022-2024 | Yupelri |
| United Therapeutics Corporation | $157.62 | 2021-2025 | Tyvaso, Tyvaso |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Viatris Specialty LLC | $71.04 | 2025 | Yupelri |
| Harmony Biosciences LLC | $62.60 | 2024-2025 | |
| Baxter Healthcare | $55.49 | 2023-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $49.20 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $48.46 | 2022-2025 | Dupixent |
| Janssen Biotech, INC. | $35.94 | 2024 | Tremfya |
| Grifols USA, LLC | $34.14 | 2021-2023 | Prolastin-C Liquid |
| Novartis Pharmaceuticals Corporation | $32.84 | 2022 | |
| Electromed, INC. | $31.86 | 2023 | Smartvest |
| Verona Pharma, INC. | $30.05 | 2025 | Ohtuvayre |
| Ethicon INC. | $29.56 | 2022 | |
| Inari Medical, INC. | $29.44 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Covis Pharma Gmbh | $24.30 | 2021 | |
| Ucb, INC. | $20.79 | 2025 | Bimzelx |
| Ani Pharmaceuticals, INC. | $17.74 | 2025 | Purified Cortrophin Gel |
| Pharming Healthcare, INC. | $16.92 | 2023 | Ruconest |
| Paratek Pharmaceuticals, INC. | $15.45 | 2023 | Nuzyra |
| Jazz Pharmaceuticals INC. | $15.25 | 2021 | |
| Axsome Therapeutics, INC. | $14.52 | 2023 | Sunosi |
| Itamar Medical INC | $13.00 | 2023 | Watchpatone |
| Merck Sharp & Dohme LLC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anish Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.